DNA Progress: Genetic drug for obesity and nerve restorer patented in Russia

News Intellectual property General Updates

Date: 25th Apr, 2025 Source: Federal Service for Intellectual Property Country: Russia Original Source

Brief

On 25/04/2025, the Federal Service for Intellectual Property issued an update regarding "DNA Progress: Genetic drug for obesity and nerve restorer patented in Russia". Notable achievements include a novel RNA complex for editing human genomes, enabling more efficient study of polygenic diseases, and super-fast DNA sequencing that can complete genome decoding within four hours with 99.9% accuracy.

This content is restricted.

Highlights content goes here...

This content is restricted.

Federal Service for Intellectual Property

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

DNA Progress: Genetic drug for obesity and nerve restorer patented in Russia

Brief

Federal Service for Intellectual Property

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

DNA Progress: Genetic drug for obesity and nerve restorer patented in Russia

Brief

Federal Service for Intellectual Property

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.